Cargando…

Adipose-derived stem cell conditioned medium for the treatment of amyotrophic lateral sclerosis: pre-clinical evidence and potential for clinical application

Detalles Bibliográficos
Autor principal:	Walker, Chandler L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557084/ https://www.ncbi.nlm.nih.gov/pubmed/31089048 http://dx.doi.org/10.4103/1673-5374.253514

Ejemplares similares

Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis
por: Riancho, Javier, et al.
Publicado: (2020)

Glaucoma and amyotrophic lateral sclerosis, two kindred diseases?
por: Carreras, Francisco Javier
Publicado: (2016)

Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet
por: Lerskiatiphanich, Titaya, et al.
Publicado: (2022)

Fibrosis as a common trait in amyotrophic lateral sclerosis tissues
por: Apolloni, Savina, et al.
Publicado: (2021)

Complement: a global immunometabolic regulator in amyotrophic lateral sclerosis
por: Lo, Martin W., et al.
Publicado: (2020)

P2X7 receptor antagonism in amyotrophic lateral sclerosis
por: Sluyter, Ronald, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis disease burden: doing better at getting better
por: Volonté, Cinzia, et al.
Publicado: (2022)

Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis
por: Fontanilla, Christine V., et al.
Publicado: (2015)

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
por: Ruiz-López, Francisco José, et al.
Publicado: (2016)

Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective
por: Tang, Bor Luen
Publicado: (2017)

Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement
por: Ramírez, Ana I., et al.
Publicado: (2021)

Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration
por: Oliveira, Danyllo, et al.
Publicado: (2021)

Stem cell-derived extracellular vesicles as potential mechanism for repair of microvascular damage within and outside of the central nervous system in amyotrophic lateral sclerosis: perspective schema
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2020)

Corrigendum: Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis
por: Fontanilla, Christine V., et al.
Publicado: (2016)

State-of-art modelling of inflammatory astrocyte-synapse interactions in injury and amyotrophic lateral sclerosis
por: Lakatos, András
Publicado: (2017)

Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosis
por: Bose, Poulomee
Publicado: (2019)

The important functional role of TDP-43 plays in amyotrophic lateral sclerosis-frontotemporal dementia
por: Chen, Liam
Publicado: (2020)

Mending the broken in amyotrophic lateral sclerosis: DNA damage and repair in motor neuron degeneration
por: Kim, Byung Woo, et al.
Publicado: (2020)

Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis?
por: Chisholm, Christen G., et al.
Publicado: (2022)

Clinical Psychology and Amyotrophic Lateral Sclerosis
por: Pagnini, Francesco, et al.
Publicado: (2010)

Systemic Dental Pulp Stem Cell Secretome Therapy in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Wang, Junmei, et al.
Publicado: (2019)

Adipose-Derived Mesenchymal Stem Cells Combined With Extracellular Vesicles May Improve Amyotrophic Lateral Sclerosis
por: Wang, Xichen, et al.
Publicado: (2022)

Understanding metabolic flexibility: a potential key to unlocking metabolic therapies in amyotrophic lateral sclerosis?
por: Allen, Scott P.
Publicado: (2020)

Degenerative and regenerative processes in amyotrophic lateral sclerosis: motor reserve, adaptation and putative compensatory changes
por: Bede, Peter, et al.
Publicado: (2020)

Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis
por: Iyer, Abhirami K., et al.
Publicado: (2018)

Chemically oligomerizable TDP-43: a novel chemogenetic tool for studying the pathophysiology of amyotrophic lateral sclerosis
por: Kanekura, Kohsuke, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
por: Corcia, Philippe, et al.
Publicado: (2012)

Amyotrophic lateral sclerosis: a clinical review
por: Masrori, P., et al.
Publicado: (2020)

Clinical Mimickers of Amyotrophic Lateral Sclerosis-Conditions We Cannot Afford to Miss
por: Singh, Nishita, et al.
Publicado: (2018)

Clinical Mimickers of Amyotrophic Lateral Sclerosis-Conditions we Cannot Afford to Miss
por: Singh, Nishita, et al.
Publicado: (2019)

Combination of novel RNA sequencing and sophisticated network modeling to reveal a common denominator in amyotrophic lateral sclerosis?
por: Dash, Banaja P., et al.
Publicado: (2023)

Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis
por: Lindauer, Eva, et al.
Publicado: (2013)

Stem Cells From Human Exfoliated Deciduous Teeth-Conditioned Medium (SHED-CM) is a Promising Treatment for Amyotrophic Lateral Sclerosis
por: Ueda, Tomoyuki, et al.
Publicado: (2022)

Stem cell therapy for amyotrophic lateral sclerosis
por: Mao, Zhijuan, et al.
Publicado: (2015)

Bisperoxovanadium promotes motor neuron survival and neuromuscular innervation in amyotrophic lateral sclerosis
por: Wang, Junmei, et al.
Publicado: (2021)

Cortical Thinning and Clinical Heterogeneity in Amyotrophic Lateral Sclerosis
por: Mezzapesa, Domenico Maria, et al.
Publicado: (2013)

Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients
por: Chen, Xueping, et al.
Publicado: (2018)

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
por: Goyal, Namita A., et al.
Publicado: (2020)

Improving clinical trial outcomes in amyotrophic lateral sclerosis
por: Kiernan, Matthew C., et al.
Publicado: (2020)

Clinical cases of amyotrophic lateral sclerosis concurrent with hydromyelia
por: Bogdanov, Enver I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_77l359pb82r91ae58qm0dk3lol